BlackRock Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$314M Buy
1,107,758
+158,870
+17% +$45.1M 0.36% 45
2016
Q3
$297M Buy
948,888
+398,171
+72% +$125M 0.37% 48
2016
Q2
$133M Sell
550,717
-258,258
-32% -$62.5M 0.17% 123
2016
Q1
$211M Sell
808,975
-288,772
-26% -$75.2M 0.27% 79
2015
Q4
$336M Buy
1,097,747
+8,756
+0.8% +$2.68M 0.43% 47
2015
Q3
$318M Buy
1,088,991
+508,272
+88% +$148M 0.43% 48
2015
Q2
$235M Buy
580,719
+53,079
+10% +$21.4M 0.29% 72
2015
Q1
$223M Sell
527,640
-14,713
-3% -$6.21M 0.29% 77
2014
Q4
$184M Sell
542,353
-512,662
-49% -$174M 0.24% 88
2014
Q3
$349M Sell
1,055,015
-107,411
-9% -$35.5M 0.49% 40
2014
Q2
$367M Buy
1,162,426
+418,438
+56% +$132M 0.49% 37
2014
Q1
$228M Buy
743,988
+80,277
+12% +$24.6M 0.33% 66
2013
Q4
$186M Sell
663,711
-18,505
-3% -$5.17M 0.28% 86
2013
Q3
$164M Buy
682,216
+30,462
+5% +$7.33M 0.27% 83
2013
Q2
$140M Buy
+651,754
New +$140M 0.25% 90